Centene Corporation to release Q2FY26 results on July 28

1 min read Updated on 11 Jul 2026, 12:57 AM

Reviewed by

Suketu GScanX News Team

AI Summary

Centene Corporation announced it will release its Q2FY26 financial results on July 28, 2026, followed by an investor conference call. The company provided dial-in numbers and access codes for live participation and replay options. Centene is a Fortune 500 healthcare enterprise serving Medicaid, Medicare, and Health Insurance Marketplace members.

*this image is generated using AI for illustrative purposes only.

Centene Corporation will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026. The company will host a conference call at 8:30 a.m. ET to review the results, providing investors with an opportunity to assess the healthcare enterprise's performance for the quarter.

Investors and interested parties can listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada, or +1-412-902-6506 (toll) from abroad. The Elite Entry Number to expedite caller registration is 4306002. Alternatively, a live audio webcast will be available on the company's website under the Investors section.

A webcast replay will be available for on-demand listening shortly after the call concludes. The replay will be accessible for the next 12 months or until 11:59 p.m. ET on Tuesday, July 27, 2027. Additionally, a digital audio playback will be available until 9 a.m. ET on Tuesday, August 4, 2026, by dialing 1-855-669-9658 (toll free) in North America or +1-412-317-0088 (toll) from abroad, using access code 6500508.

Conference Call Details

Access Method	Number	Access Code
U.S. & Canada (Toll Free)	1-877-883-0383	4306002
International (Toll)	+1-412-902-6506	4306002
North America Replay	1-855-669-9658	6500508
International Replay	+1-412-317-0088	6500508

Centene Corporation, a Fortune 500 company, provides integrated healthcare services to government-sponsored and commercial programs. The company focuses on under-insured and uninsured individuals, offering products to Medicaid and Medicare members, as well as those served by the Health Insurance Marketplace.

What key financial metrics will investors focus on during the Q2 2026 earnings call?

How might changes in Medicaid or Medicare policies impact Centene's performance in the second quarter?

What strategic initiatives or market expansions is Centene likely to highlight during the call?

Read Next Article

Analysts raise Centene price targets to $75 and $71

0 min read Updated on 10 Jul 2026, 01:49 AM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

AI Summary

Cantor Fitzgerald analyst Sarah James maintained an Overweight rating on Centene and raised the price target to $75 from $60. RBC Capital analyst Ben Hendrix maintained a Sector Perform rating and increased the price target to $71 from $70.

*this image is generated using AI for illustrative purposes only.

Cantor Fitzgerald and RBC Capital have both raised their price targets for Centene (NYSE: CNC), reflecting a positive outlook for the healthcare company's stock performance. Cantor Fitzgerald analyst Sarah James increased the target to $75 from $60 while maintaining an Overweight rating. Separately, RBC Capital analyst Ben Hendrix lifted the target to $71 from $70 with a Sector Perform rating.

The revised targets suggest confidence in Centene's business fundamentals and growth trajectory. Cantor Fitzgerald's increase to $75 represents a significant jump from the previous estimate of $60, while RBC Capital's adjustment to $71 indicates a modest upward revision.